10.1038/s41467-022-28848-x - The evolution of RET inhibitor resist...

This document has been corrected

The evolution of RET inhibitor resistance in RET-driven lung and thyroid cancers

10.1038/s41467-022-28848-x

Published Online: 2022-03-18

Journal: Nature Communications•Publisher: Springer Science and Business Media LLC

Authors: Alexander Drilon•Barbara J. Brandhuber•Barry S. Taylor•Caitlin Bourque•Casey Savin•Catherine Zimel•Christina Falcon•Craig M. Bielski•David M. Hyman•Duygu Selcuklu•Emiliano Cocco•Eric J. Sherman•Ezra Y. Rosen•Fan Wu•Fanli Meng•Helen H. Won•Ino de Bruijn•James Fagin•Jennifer Kherani•Kevin Ebata•Marc Ladanyi•Maurizio Scaltriti•Michael F. Berger•Natasha Rekhtman•Nikeysha Clarke•Noah D. Friedman•Onur Sumer•Sophie Shifman•Srushti Kittane•Xiaohong Jing•Yixiao Gong•Youyun Zheng

This document has been corrected

The evolution of RET inhibitor resistance in RET-driven lung and thyroid cancers

10.1038/s41467-022-28848-x

Published Online: 2022-03-18

Journal: Nature Communications

NOW

2022-04-05•Correction

Author Correction: The evolution of RET inhibitor resistance in RET-driven lung and thyroid cancers

10.1038/s41467-022-29700-y

* information provided by CrossRef

2022-04-05•Correction

10.1038/s41467-022-29700-y

* information provided by CrossRef

2022-03-18•Published

2022-04-05•Correction

Author Correction: The evolution of RET inhibitor resistance in RET-driven lung and thyroid cancers

10.1038/s41467-022-29700-y

* information provided by CrossRef

This document has been corrected

The evolution of RET inhibitor resistance in RET-driven lung and thyroid cancers

10.1038/s41467-022-28848-x

Published Online: 2022-03-18

Journal: Nature Communications•Publisher: Springer Science and Business Media LLC